CD40 Ligand Stimulation Inhibits the Proliferation of Mantle Cell Lymphoma Lines

Zaishun Jin, Norihiro Teramoto, Kazuhiko Hayashi, Yi Xuan Liu, Guishun Jin, Takashi Oka, Kiyoshi Takahashi, Tadashi Yoshino, Tadaatsu Akagi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Mantle cell lymphoma (MCL) is a CD5+ non-Hodgkin's B-cell lymphoma characterized by the infiltration of intermediate sized B-cells into the mantle zones. Interaction between CD40L and CD40 is important for B cell proliferation and differentiation. CD40L stimulation can induce both growth arrest and proliferation of B cell lines according to their differentiation state. Previous reports examining the effect of stimulation via the CD40 cascade on ex vivo MCL cells have provided conflicting results. In this study, two MCL lines, SP49 and SP53, were examined for response to CD40L and/or IL-10. Co-cultivation with CD40L-expressing mouse L cells reduced the BrdU incorporation of SP49 and SP53 cells by half to one-third, while BrdU incorporation of control cell lines, including Ramos, BJAB and BALL-1, was not affected or increased Anti-CD40L antibody blocked the CD40L inhibition of SP49 cell proliferation in a dose-dependent manner in the range from 0 to 20 ng/mL IL-10 did not affect MCL cell proliferation in the presence or absence of CD40L-expressing cells, while Ramos proliferation was promoted by CD40L and IL-10. These results suggested the possibility that CD40L may also inhibit MCL proliferation in vivo.

Original languageEnglish
Pages (from-to)691-697
Number of pages7
JournalAnticancer Research
Volume24
Issue number2 B
Publication statusPublished - Mar 2004

Fingerprint

Mantle-Cell Lymphoma
CD40 Ligand
Cell Line
Cell Proliferation
Interleukin-10
B-Lymphocytes
Bromodeoxyuridine
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Cell Differentiation
Anti-Idiotypic Antibodies

Keywords

  • CD40
  • CD40 ligand
  • IL-10
  • Mantle cell lymphoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Jin, Z., Teramoto, N., Hayashi, K., Liu, Y. X., Jin, G., Oka, T., ... Akagi, T. (2004). CD40 Ligand Stimulation Inhibits the Proliferation of Mantle Cell Lymphoma Lines. Anticancer Research, 24(2 B), 691-697.

CD40 Ligand Stimulation Inhibits the Proliferation of Mantle Cell Lymphoma Lines. / Jin, Zaishun; Teramoto, Norihiro; Hayashi, Kazuhiko; Liu, Yi Xuan; Jin, Guishun; Oka, Takashi; Takahashi, Kiyoshi; Yoshino, Tadashi; Akagi, Tadaatsu.

In: Anticancer Research, Vol. 24, No. 2 B, 03.2004, p. 691-697.

Research output: Contribution to journalArticle

Jin, Z, Teramoto, N, Hayashi, K, Liu, YX, Jin, G, Oka, T, Takahashi, K, Yoshino, T & Akagi, T 2004, 'CD40 Ligand Stimulation Inhibits the Proliferation of Mantle Cell Lymphoma Lines', Anticancer Research, vol. 24, no. 2 B, pp. 691-697.
Jin Z, Teramoto N, Hayashi K, Liu YX, Jin G, Oka T et al. CD40 Ligand Stimulation Inhibits the Proliferation of Mantle Cell Lymphoma Lines. Anticancer Research. 2004 Mar;24(2 B):691-697.
Jin, Zaishun ; Teramoto, Norihiro ; Hayashi, Kazuhiko ; Liu, Yi Xuan ; Jin, Guishun ; Oka, Takashi ; Takahashi, Kiyoshi ; Yoshino, Tadashi ; Akagi, Tadaatsu. / CD40 Ligand Stimulation Inhibits the Proliferation of Mantle Cell Lymphoma Lines. In: Anticancer Research. 2004 ; Vol. 24, No. 2 B. pp. 691-697.
@article{6ae5b78c404f4743b47606d34ea22ccf,
title = "CD40 Ligand Stimulation Inhibits the Proliferation of Mantle Cell Lymphoma Lines",
abstract = "Mantle cell lymphoma (MCL) is a CD5+ non-Hodgkin's B-cell lymphoma characterized by the infiltration of intermediate sized B-cells into the mantle zones. Interaction between CD40L and CD40 is important for B cell proliferation and differentiation. CD40L stimulation can induce both growth arrest and proliferation of B cell lines according to their differentiation state. Previous reports examining the effect of stimulation via the CD40 cascade on ex vivo MCL cells have provided conflicting results. In this study, two MCL lines, SP49 and SP53, were examined for response to CD40L and/or IL-10. Co-cultivation with CD40L-expressing mouse L cells reduced the BrdU incorporation of SP49 and SP53 cells by half to one-third, while BrdU incorporation of control cell lines, including Ramos, BJAB and BALL-1, was not affected or increased Anti-CD40L antibody blocked the CD40L inhibition of SP49 cell proliferation in a dose-dependent manner in the range from 0 to 20 ng/mL IL-10 did not affect MCL cell proliferation in the presence or absence of CD40L-expressing cells, while Ramos proliferation was promoted by CD40L and IL-10. These results suggested the possibility that CD40L may also inhibit MCL proliferation in vivo.",
keywords = "CD40, CD40 ligand, IL-10, Mantle cell lymphoma",
author = "Zaishun Jin and Norihiro Teramoto and Kazuhiko Hayashi and Liu, {Yi Xuan} and Guishun Jin and Takashi Oka and Kiyoshi Takahashi and Tadashi Yoshino and Tadaatsu Akagi",
year = "2004",
month = "3",
language = "English",
volume = "24",
pages = "691--697",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2 B",

}

TY - JOUR

T1 - CD40 Ligand Stimulation Inhibits the Proliferation of Mantle Cell Lymphoma Lines

AU - Jin, Zaishun

AU - Teramoto, Norihiro

AU - Hayashi, Kazuhiko

AU - Liu, Yi Xuan

AU - Jin, Guishun

AU - Oka, Takashi

AU - Takahashi, Kiyoshi

AU - Yoshino, Tadashi

AU - Akagi, Tadaatsu

PY - 2004/3

Y1 - 2004/3

N2 - Mantle cell lymphoma (MCL) is a CD5+ non-Hodgkin's B-cell lymphoma characterized by the infiltration of intermediate sized B-cells into the mantle zones. Interaction between CD40L and CD40 is important for B cell proliferation and differentiation. CD40L stimulation can induce both growth arrest and proliferation of B cell lines according to their differentiation state. Previous reports examining the effect of stimulation via the CD40 cascade on ex vivo MCL cells have provided conflicting results. In this study, two MCL lines, SP49 and SP53, were examined for response to CD40L and/or IL-10. Co-cultivation with CD40L-expressing mouse L cells reduced the BrdU incorporation of SP49 and SP53 cells by half to one-third, while BrdU incorporation of control cell lines, including Ramos, BJAB and BALL-1, was not affected or increased Anti-CD40L antibody blocked the CD40L inhibition of SP49 cell proliferation in a dose-dependent manner in the range from 0 to 20 ng/mL IL-10 did not affect MCL cell proliferation in the presence or absence of CD40L-expressing cells, while Ramos proliferation was promoted by CD40L and IL-10. These results suggested the possibility that CD40L may also inhibit MCL proliferation in vivo.

AB - Mantle cell lymphoma (MCL) is a CD5+ non-Hodgkin's B-cell lymphoma characterized by the infiltration of intermediate sized B-cells into the mantle zones. Interaction between CD40L and CD40 is important for B cell proliferation and differentiation. CD40L stimulation can induce both growth arrest and proliferation of B cell lines according to their differentiation state. Previous reports examining the effect of stimulation via the CD40 cascade on ex vivo MCL cells have provided conflicting results. In this study, two MCL lines, SP49 and SP53, were examined for response to CD40L and/or IL-10. Co-cultivation with CD40L-expressing mouse L cells reduced the BrdU incorporation of SP49 and SP53 cells by half to one-third, while BrdU incorporation of control cell lines, including Ramos, BJAB and BALL-1, was not affected or increased Anti-CD40L antibody blocked the CD40L inhibition of SP49 cell proliferation in a dose-dependent manner in the range from 0 to 20 ng/mL IL-10 did not affect MCL cell proliferation in the presence or absence of CD40L-expressing cells, while Ramos proliferation was promoted by CD40L and IL-10. These results suggested the possibility that CD40L may also inhibit MCL proliferation in vivo.

KW - CD40

KW - CD40 ligand

KW - IL-10

KW - Mantle cell lymphoma

UR - http://www.scopus.com/inward/record.url?scp=2442619321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442619321&partnerID=8YFLogxK

M3 - Article

C2 - 15161013

AN - SCOPUS:2442619321

VL - 24

SP - 691

EP - 697

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2 B

ER -